LIST OF PUBLICATIONS

 

BOOKS

 

1.      Haynes C, Gillman MA (1992)

 

            Death the Last Great Adventure. Bizbee, U.S.A: Nomad Press.

 

2.       Gillman MA (1995)

 

          Stress - The change factor. Bizbee, U.S.A: Nomad Press.

 

3.    Gillman MA (1996)

 

          Envy as a retarding force in science. U.K. Aldershot: Avebury.

 

4.         Gillman MA (2004-2005)    

 

            Psychotropic Analgesic Nitrous Oxide (PAN) Sedation 1st Edition – Textbook (in CD form).

 

5.         Gillman MA (2004-2007)

 

            Psychotropic Analgesic Nitrous Oxide (PAN) Sedation 2nd Edition – Textbook (in CD form).

 

 

 

OTHER PUBLICATIONS  (Articles, Book Chapters & Letters to The Editor)

 

 

1.    Gillman MA, Lichtigfeld FJ (1980) Nitrous oxide: treatment of withdrawal symptoms.  Lancet 2: 803.

 

2.    Gillman MA, Kok L, Lichtigfeld FJ (1980) Paradoxical effect of naloxone on nitrous oxide analgesia in man. Eur J Pharmacol 61: 175-177.

 

3.    Gillman MA, Lichtigfeld FJ (1981) A comparison of the effect of morphine sulphate and nitrous oxide analgesia on chronic pain states in man. J Neurol Sci 45: 41-45

 

4.    Gillman MA, Lichtigfeld FJ (1981) The similarity of the action of nitrous oxide and morphine. Pain 10: 110

 

5.   Gillman MA, Kimmel I, Lichtigfeld FJ (1981) The dual system hypothesis of pain perception. Neurolog Res. 3 : 317-327

 

6.    Gillman MA, Footerman D (1981) The need for a clearer distinction between anesthesia and analgesia in relation to the opiate system.  Anesthesiology 54: 524

 

7.    Gillman MA, Lichtigfeld FJ (1981) Naloxone in Anorexia Nervosa - The role of the opiate system. J. Roy Soc Med 74: 631-632

 

8.    Gillman MA, Lichtigfeld FJ (1981) The almighty referee. New scientist 90: 644

 

9.    Gillman MA, Lichtigfeld FJ (1981) Management of alcohol withdrawal symptoms.

Brit Med J 203 : 64

 

10   Lichtigfeld FJ, Gillman MA (1982) The treatment of alcoholic withdrawal states with oxygen and nitrous oxide. S Afr Med J 61: 349-351

 

 

11.  Gillman MA, Lichtigfeld FJ (1981) The endorphins and stress.  S Afr Med J 61: 126

 

12.  Gillman MA, Lichtigfeld FJ (1981) The opiate system in traumatic brain death. Lancet 2: 156

 

13.  Gillman MA, Lichtigfeld (1981) Anorexia nervosa - A stress syndrome.  S Afr Med J 60: 376-377

 

14.  Gillman MA, Lichtigfeld FJ (1981) Naloxone and cerebral ischaemia. Lancet 2: 643

 

15.  Gillman MA, Lichtigfeld FJ (1981) Management of alcohol withdrawal symptoms.  Brit Med J 283: 674

 

16.  Gillman MA, Lichtigfeld FJ (1981) Cabal of referees. Nature 291: 608

 

17.  Gillman MA, Lichtigfeld FJ (1981) Solicited testimonials.  New scientist 91: 368

 

18.  Gillman MA, Footerman DS and Lichtigfeld FJ (1982) Nitrous oxide and anti-stress agent?  Anesthesiology 56: 234-235

 

19.  Gillman MA, Lichtigfeld FJ (1982) Possible drug differentiation of the psychoses. Am J Psychiatry 139: 384

 

20.  Gillman MA (1982) Nitrous oxide at analgesic concentrations an opiate agonist. Further evidence.  Anesth. Analg. 61: 394

 

21.  Gillman MA, Lichtigfeld FJ (1983) The effect of nitrous oxide and naloxone on orgasm in human females. A Preliminary report.  J.Sex Res 19: 49-57

 

22.  Gillman MA (1982) The principles of prescribing anti-microbial (anti-biotics)agents in dentistry.  J Dent Assoc S Afr 37: 191-192

 

23.  Gillman MA (1982) Anti-microbial agents used in dentistry - Part 1. J Dent Assoc S Afr 37: 9 657-658

 

24.  Gillman MA, Lichtigfeld FJ (1982) Oestrogen and parkinsonism. S Afr Med J 62: 46

 

25.  Gillman MA, Lichtigfeld FJ (1981) The possibility of an opiate and anti-opiate system.           J. Roy Soc Med. 74: 943

 

26.  Gillman MA, Lichtigfeld FJ (1983) Receptor hypothesis of the alcohol withdrawal state: CNS receptor- from molecular pharmacology to behaviour.  In: advances in biochemical psychopharmacology  V 37 Raven Press New York pp. 405-415

 

27. Gillman MA (1984) The possibility that nitrous oxide at analgesic concentrations is an opiate receptor agonist.  J. Soc Adv Anaesth Dent 5: 244-248

 

28.  Gillman MA, Lichtigfeld FJ (1983) Naloxone and its analeptic effect. Anesthesiology 58:287

 

29.  Gillman MA, Lichtigfeld FJ (1982) Dual system hypothesis of pain perception: Possible further evidence. Anesth Analg 61: 886-889

 

30.    Lichtigfeld FJ Gillman MA, (1983) The treatment of alcoholic withdrawal states with oxygen and nitrous oxide. S Afr Med J 63: 65-66

 

31.  Gillman MA, Lichtigfeld FJ (1982) Naloxone for alcohol intoxication.  Lancet 2: 558

 

32.  Gillman MA (1982) Possible dangers of naloxone use  J Am Med Assoc 248:2972-2973

 

33.  Gillman MA, Lichtigfeld FJ (1982) Intraspinal opiates and itching.  A New Reflex?

   Brit Med J 285: 1950

 

34.    Gillman MA (1982) Anti-microbial agent used in dentistry - Part 2. J Dent Assoc S Afr 37: 747-750

 

35.  Gillman MA, Lichtigfeld FJ (1982) Paradoxical effect of naloxone on nitrous oxide analgesia.  Brit J Anaesth 55: 91

 

36.  Gillman MA, Lichtigfeld FJ (1983) Nitrous oxide interacts with opioid receptors: More evidence.  Anesthesiology 58: 85-86

 

37.  Gillman MA (1982) Anti microbial agent used in dentistry - Part 3 Therapeutic notes. J Dent Assoc S Afr 38: 18-19

 

38.  Gillman (1982) The safety of nitrous oxide. Lancet 2: 1397

 

39.  Gillman MA, Lichtigfeld FJ (1983) The opiate system in Anorexia Nervosia Am J Psychiatry 140:371

 

40.  Gillman MA (1983) On peer review. S Afr Med J 63: 432

 

41.  Daras C, Cantrill RC and Gillman MA (1983) (3H)Naloxone displacement: evidence for nitrous oxide as opioid receptor agonist.  Eur J Pharmacol 89:177-178

 

42.  Gillman MA (1983) Antimicrobial aspects of treating osteomyelitis of the jaws and maxillo facial fractures.  J Dent Assoc S Afr 38: 493

 

43.  Gillman MA, Lichtigfeld FJ (1983) The opiate and anti-opiate system.  Evidence from involvement in withdrawal responses.  Can Anaesth Soc J 30:564-565

 

44.  Gillman MA, Lichtigfeld FJ (1983) The effect of naloxone on nitrous oxide analgesia.

  Pain 17: 103-104

 

45.  Lichtigfeld FJ, Gillman MA (1983) Treatment of alcoholic withdrawal state with oxygen and nitrous oxide.  Psychiat Digest (June) pp12-13

 

46.  Lichtigfeld FJ, Gillman MA (1982) Oxygen or laughing gas for alcohol withdrawal. Medicine Digest 8: 57

 

47.  Gillman MA, Sandyk R (1984) Parkinsonism induced by methyldopa.  S Afr Med J 65:194

 

48.  Gillman MA (1983) Pharmacology of analgesic agent used in Dentistry-Part 1.  J Dent Assoc S Afr 38:575-576

 

49.  Gillman MA (1983) Pharmacology of analgesic agent used in dentistry - Part 2.  J Dent Assoc S Afr 38: 697-698

 

50.  Gillman MA (1983) Antibiotic prophylaxis of infective endocarditis.  J Dent Assoc S Afr 38: 693

 

51.  Gillman MA, Sandyk R (1984) Tourette syndrome: Effect of analgesic concentrations of nitrous oxide and naloxone.  Brit Med J 288: 114

 

52.  Gillman MA, Sandyk R (1984) Haematuria following tricyclic therapy. Am J Psychiatry 141:463-464

 

53.  Gillman MA, Lichtigfeld FJ, (1983) The crisis-emergency pharmacotherapy.  S Afr Med J 65: 153-154

 

54.  Gillman MA, Lichtigfeld FJ (1984) An opioid involvement in Anorexia Nervosa - Further studies needed.  S Afr Med J 65: 4

 

55.  Sandyk R, Gillman MA (1983) Chronic bromocriptine therapy causes urinary incontinence.  Lancet 2: 1260-126

 

56.  Gillman MA, Sandyk R (1984) Bilateral internuclear ophthalmopogia reversed by naloxone.Arch Neurol 41:703

 

57.  Gillman MA, Lichtigfeld FJ, Sandyk R (1984) Subacute toxic delirium caused by nitrous oxide may be an acute withdrawal state.  Arch Neurol 41:704

 

58. Gillman MA, Sandyk R (1984) Nicotinic acid deficiency induced by sodium valproate.  S Afr Med J 65: 986

 

59. Gillman MA (1984) Naloxone and its antagonism of anesthesia and analgesia.  Can Anaesth Soc. J 31: 117-118

 

60. Sandyk R, Gillman MA (1986) The opioid system in the restless legs and nocturnal myoclonus Syndromes.  Sleep 9: 370-371

 

61.  Gillman MA, Sandyk R(1984) Hemifacial spasm - successful treatment with Baclofen.  S Afr Med J 65: 502

 

62. Gillman MA (1984) The hypertensive response to naloxone - A Commentary.  S Afr Med J 66: 551-552

 

63. Sandyk R, Gillman MA (1984) Motor dysfunction following chronic exposure to a flouroalkane solvent mixture containing nitromethane.  Eur Neurol 23: 479 - 480

 

64. Gillman MA (1984) Possible mechanisms of action of nitrous oxide at the opioid receptor.  Med Hypotheses 15: 109 - 114

 

65. Gillman MA, Sandyk R (1984) Nomifensine exacerbates depression and seizures in an epileptic patient. Neurology 34: 1620 - 1621

 

66. Sandyk R, Gillman MA (1985) Transient gilles de la Tourett Syndrome following alcohol withdrawal. Brit J Addiction 80: 213-214

 

67. Sandyk R, Gillman MA (1984) Naloxone of no benefit in levodopa-induced hallucinations in Parkinson's Disease.  Ann Neurol 16: 723

 

68. Sandyk R, Gillman MA (1984) Nor-adrenalin and tardive dyskinesia. Brit J Psychiatry 145: 217

 

69.  Sandyk R, Gillman MA (1984) Acute exacerbation of Parkinson's Disease with sulindac. Ann Neurol 17: 104-105

 

70.  Sandyk R, Gillman MA (1984) Blepharospasm associated with brainstem lesions. Neurology 34:1522-1423

 

71.  Gillman MA, Sandyk R (1985) Reversal of captopril-induced psychosis with naloxone.  Am J Psychiatry 142: 270,

 

72.  Sandyk R, Gillman MA (1984) Restless Leg Syndrome associated with amitriptyline.

Brit Med J 289: 162

 

73.  Lichtigfeld FJ, Gillman MA (1985) The therapeutic uses of opioid substances in psychiatry, with special reference to analgesic concentrations of nitrous oxide.  Update of psychiatric management, The Society of Psychiatrists SA ed. J.B. Carlile pp 76 - 79.

 

74.  Gillman MA  Nitrous oxide as an experimental investigative tool in medicine - An overview. in neuropsychology II, Proceedings of the 2nd S.A.  Neuropsychology Conference in Pretoria 1985 pp.63 - 66.

 

75.  Cantrill RC, Wallard DD, Daras C & Gillman MA Nitrous oxide: Its application in receptor binding studies  In Neuropsychology II, Proceedings of the 2nd S.A. Neuro­  psychology Conference in Pretoria 1985 pp. 73 - 82.

 

76.  Gillman MA, Lichtigfeld FJ (1984) The opioid and anti opioid system in addiction.    S Afr Med J 66:592

 

77.  Sandyk R, Gillman MA (1985) Nomifensine exacerbates oro-facial dyskinesia in hypothyroidism. neurology 35: 282 1985

 

78.  Sandyk R, Gillman MA (1985) Opioid hypofunction In Parkinson's Disease.  Med Hypotheses 16: 179-182

 

79.  Sandyk R, Gillman MA (1984) Colchicine ameliorates constipation in Parkinsonism. J Roy Soc Med 77: 1066

 

80.  Gillman MA, Sandyk R, Lichtigfeld FJ (1984) Evidence for underactivity of the opioid system in neuroleptic induced akathisia.  Psychiat Res 13: 187

 

81.  Sandyk R, Gillman MA (1987)  Baclofen in hemifacial spasm.  Int J Neurosci 33: 261-264

 

82.  Gillman MA,  Lichtigfeld FJ (1985) Nitrous oxide acts directly at Mu Opioid Receptors.  Anesthesiology 62: 375

 

83.  Gillman MA (1983) Adventure with nitrous oxide.  Proceedings of the Mine Medical Officer's Association of S.A. 62: 21

 

84.  Sandyk R, Gillman MA (1985) Nifedipine-induced psychosis. J Am Geriatric Soc 33: 154

 

85.  Sandyk R, Gillman MA (1985) Naloxone ameliorates narcolepsy.  Clin Neuropharmacol 8: 96-97

 

86.  Sandyk R, Gillman MA (1985) Nomifensine exacerbates narcolepsy.  Neurology 35: 138-139

 

87.  Gillman MA, Sandyk R (1985) Possible impact of weekly DST's on thyroid function in patients with affective disorders.  Am J Psychiatry 142: 662-663

 

88.  Gillman MA, Lichtigfeld FJ (1986)Minimal sedation required with nitrous oxide – oxygen treatment of the alcohol withdrawal state Brit J Psychiatry 148: 604-606

 

89.  Gillman MA, Sandyk R (1985) Opioid induced unconsciousness reversed by changes in opioid cholinergic and adrenergic function.  J Neurol, Neurosurg & Psychiat 48: 391

 

90.  Sandyk R, Gillman MA (1985) Nomifensine for emotional incontinence in the elderly. Clin Neuropharmacol 8: 377-378

 

91.  Gillman MA, Lichtigfeld FJ (1985) Nitrous oxide analgesia and the endogenous opioid system.  Can Anaesth Soc J 32: 200-201

 

92.  Gillman MA (1985) Cholecystokinin dopamine and the endogenous opioid system in

Schizophrenia. TIPS 6 (2): 64

 

93.  Sandyk R, Gillman MA (1985) Lithium induced visual hallucinations:  Evidence for possible opioid mediation.  Ann Neurol 17: 619-620

 

94.  Sandyk R, Gillman MA (1987) Phenelzine in migraine headaches.  Int J Neurosci 35: 243

 

95.  Sandyk R, Gillman MA (1986) Naloxone causes urinary urgency.  Urology 27: 79

 

96.  Sandyk R, Gillman MA (1985) Baclofen-induced memory impairment. Clin Neuropharmacol 8: 294-295

 

97.  Gillman MA, Sandyk R (1985) Auto-tolerance to the endogenous opioids and sleep. medical hypotheses 16: 393-395

 

98.  Sandyk R, Gillman MA (1985) Piracetam causes confusion in a patient with temporal lobe epilepsy.  J Amer Geriatric Soc 33: 305

 

99.  Gillman MA, Sandyk R (1985) Nitrous oxide ameliorates Spasmodic Torticollis.  Eur Neurol 24: 292 - 293

 

100.  Gillman MA, Lichtigfeld FJ (1984) Recovery after brain injury-some neurotransmitter and clinical implication.  Brit J Anaesth 56: 1319

 

101   Gillman MA (1985) Referees as arbiters of scientific contributions to the literature.               J Dent Assoc S. Afr 40: 140.

 

102.  Sandyk R, Gillman MA (1985) Depression as a cause of hallucinations in Parkinson's Disease. Clin Neuropharmacol 8: 199-200

 

103.  Gillman MA, Matussek N and Lichtigfeld FJ  Effect of Nitrous oxide on depressive patients and volunteers, In: Psychiatry: The State of the Art,Vol.2 pp. 397-404 (ed P Berner) Plenum Publishing New York 1985

 

104.  Gillman MA (1985) Anesthesia and analgesia are mediated by different mechanisms. Anesth and Analg 64: 752

 

105. Sandyk R, Gillman MA (1985) Maprotiline in nocturnal enuresis.  J Clin Psychiatry 46: 546

 

106.  Gillman MA, Lichtigfeld FJ (1985) High dose dihydrocodeine produces hyperalgesia.  J Roy Soc Med 78: 697-698

 

107.  Gillman MA, Sandyk R (1985) Response to opioids in 3 patients with restless leg syndrome. Am J Psychiatry 142: 662

 

108.  Gillman MA (1985) Naloxone and hypertension.  S Afr Med J 68: 73-74

 

109.  Gillman MA (1985) Nitrous oxide as an opioid and the association between the therapeutic use of narcotics and addiction.  Postgrad Med J 61: 653

 

110.  Gillman MA, Lichtigfeld FJ (1985) Analgesic nitrous oxide : Adjunct to clonidine for opioid withdrawal.  Am J Psychiatry 142: 784-785

 

111.  Sandyk R, Gillman MA (1985) Phenytoin toxicity induced by co-trimoxazole treatment.  Ann Int Med 102: 559

 

112. Gillman MA (1985) Nitrous oxide and its opioid emetic properties.  Canad Anaesth Soc J 32: 315

 

113.  Gillman MA,  Lichtigfeld FJ (1985) A pharmacological overview of opioid mechanisms mediating analgesia and hyperalgesia.  Neurological Res. 7:106-119

 

114.  Sandyk R,  Gillman MA (1985) Infantile autism: A dysfunction of the opioids? Med   Hypotheses 19: 41-45

 

115.  Gillman MA,  Sandyk R (1985) Tourette Syndrome and the opioid system. Psychiatry Res 15: 161-162

 

116.  Gillman MA,  Sandyk R (1986) Parkinsonism induced by a monoamine oxidase inhibitor.  Postgrad Med J 62: 235-236

 

117. Gillman MA (1986) "Nitrous oxide, an opioid addictive agent" Review of the evidence.  Am J Medicine 81: 92-102

 

118.  Sandyk ,R Gillman MA (1985) Cerebral glucose utilization in Parkinson's Diseases.             J Neurol Neurosurg Psychiatry 48: 489

 

119. Gillman MA,  Lichtigfeld FJ (1985) The endogenous opioid system and Anorexia Nervosa.  S.Afr. Med J 68: 454

 

120. Gillman MA (1986) Alcohol improves dystonia: opioid system involvement? Neurology 36: 303

 

121. Gillman MA,  Lichtigfeld FJ (1986) The opioids, dopamine cholecystokinin and eating disorders.  Clin Neuropharmacol 9: 91-97

 

122.  Lichtigfeld FJ  Gillman MA (1985) The use of sulphur hyperthermia in cancer. Eur J Surg Oncol 11: 299

 

123.  Gillman MA, Sandyk R (1985) Opiatergic and dopaminergic function and Lesch Nyhan Syndrome.  Am J Psychiatry 142: 1226

 

124.  Gillman MA (1985) Analgesic nitrous oxide: as an aphrodisiac.  Med Sex J S Afr 3:6

 

125.  Sandyk R, Gillman MA (1986) Tardive dyskinesia and glucose metabolism.

  Arch Gen Psychiat 43 : 192-3.

 

126.  Gillman MA, Lichtigfeld FJ (1985)  Lithium and Bulimia : The role of the dopaminergic and opiatergic system.  Am J. Psychiatry 142 :1522-3.

 

127. Gillman MA,  Lichtigfeld FJ (1986) Is nitrous oxide the primordial opioid substance? S. Afr. J Sci 82: 10

 

128.  Gillman MA,  Lichtigfeld FJ (1986) Naloxone morphine synergism :  Support for dual system  Hypothesis of pain perception.